Sun Pharmaceutical Industries’ shares may gain on unit Taro Pharmaceutical Industries’ earnings.
Taro’s margins increased by 70 bps to a record of 81.4 per cent, beating estimates, according to analysts.
Taro says Q3 sales rose 11.3 per cent to $237.7 million.
Sun Pharma’s October-December earnings will beat estimates on account of Taro’s performance, according to traders.
The company will announce quarterly earnings on Saturday, says BSE data.